Floatz logo

Clozapine

Safety and Efficacy

Ruijin HospitalSmall moleculeEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Safety and Efficacy cohort.

Asset / SponsorPhaseRating
Tucidinostat
Sun Yat-sen University
Phase 2BB
L-Dep
Sun Yat-sen University
Phase 2CCC
Azacitidine
Sun Yat-sen University
Phase 2CCC
Tisagenlecleucel
The First Affiliated Hospital of Soochow University
Phase 1/2CCC
Jwcar129
The First Affiliated Hospital of Soochow University
Phase 1CC
Car-Nk Cells Targeting Nkg2D Ligands
Hangzhou Cheetah Cell Therapeutics Co., Ltd
N/AD

Same molecule, other indications

Clozapine is also rated in:

Psychotic DisorderDormant
BBB
Indicative ·
78 / 100
View asset →
Dual DiagnosisDormant
BB
Indicative ·
70 / 100
View asset →
schizophreniaDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →